Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.96−0.01 (-0.51%)
Close on Nov 13, 2026Market cap $609.23MP/E –Yield 0.00%
Pacific Biosciences of California cash
Cash and short-term investments held at the end of each period.
Pacific Biosciences of California's cash was $199.42M at Sep 30, 2026. For fiscal 2025 it was $279.51M, down 28.7% from the year before. Over ten years it grew 12.4% a year on average. The highest annual figure on record is $1.05B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $279.51M | -28.7% |
| FY2024 | Dec 31, 2024 | $392.15M | -37.9% |
| FY2023 | Dec 31, 2023 | $631.42M | -18.6% |
| FY2022 | Dec 31, 2022 | $775.54M | -26.1% |
| FY2021 | Dec 31, 2021 | $1.05B | +224.8% |
| FY2020 | Dec 31, 2020 | $323.15M | +505.2% |
| FY2019 | Dec 31, 2019 | $53.40M | -47.9% |
| FY2018 | Dec 31, 2018 | $102.40M | +62.8% |
| FY2017 | Dec 31, 2017 | $62.90M | -12.6% |
| FY2016 | Dec 31, 2016 | $72.00M | -17.0% |
| FY2015 | Dec 31, 2015 | $86.77M | -14.4% |
| FY2014 | Dec 31, 2014 | $101.35M | -9.9% |
| FY2013 | Dec 31, 2013 | $112.53M | +11.9% |
| FY2012 | Dec 31, 2012 | $100.58M | -43.3% |
| FY2011 | Dec 31, 2011 | $177.43M | -37.5% |
| FY2010 | Dec 31, 2010 | $283.67M | +217.9% |
| FY2009 | Dec 31, 2009 | $89.23M | +13.7% |
| FY2008 | Dec 31, 2008 | $78.46M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $199.42M | -33.2% |
| Q2 FY2026 | Jun 30, 2026 | $236.87M | -24.7% |
| Q1 FY2026 | Mar 31, 2026 | $275.96M | -19.6% |
| Q4 FY2025 | Dec 31, 2025 | $279.51M | -28.7% |
| Q3 FY2025 | Sep 30, 2025 | $298.65M | -36.6% |
| Q2 FY2025 | Jun 30, 2025 | $314.74M | -38.3% |
| Q1 FY2025 | Mar 31, 2025 | $343.11M | -38.9% |
| Q4 FY2024 | Dec 31, 2024 | $392.15M | -37.9% |
| Q3 FY2024 | Sep 30, 2024 | $471.15M | -38.6% |
| Q2 FY2024 | Jun 30, 2024 | $509.80M | -38.6% |
| Q1 FY2024 | Mar 31, 2024 | $561.91M | -35.8% |
| Q4 FY2023 | Dec 31, 2023 | $631.42M | -18.6% |
| Q3 FY2023 | Sep 30, 2023 | $767.79M | -8.0% |
| Q2 FY2023 | Jun 30, 2023 | $829.86M | -7.7% |
| Q1 FY2023 | Mar 31, 2023 | $874.89M | -9.1% |
| Q4 FY2022 | Dec 31, 2022 | $775.54M | -26.1% |
| Q3 FY2022 | Sep 30, 2022 | $834.34M | -22.7% |
| Q2 FY2022 | Jun 30, 2022 | $899.15M | -21.4% |
| Q1 FY2022 | Mar 31, 2022 | $962.78M | -17.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.05B | +224.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.08B | +417.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.14B | +853.9% |
| Q1 FY2021 | Mar 31, 2021 | $1.16B | +713.7% |
| Q4 FY2020 | Dec 31, 2020 | $323.15M | +505.2% |
| Q3 FY2020 | Sep 30, 2020 | $208.55M | +323.8% |
| Q2 FY2020 | Jun 30, 2020 | $119.96M | +79.5% |
| Q1 FY2020 | Mar 31, 2020 | $142.59M | +72.0% |
| Q4 FY2019 | Dec 31, 2019 | $53.40M | -47.9% |
| Q3 FY2019 | Sep 30, 2019 | $49.20M | -57.5% |
| Q2 FY2019 | Jun 30, 2019 | $66.84M | +5.3% |
| Q1 FY2019 | Mar 31, 2019 | $82.90M | +4.6% |
| Q4 FY2018 | Dec 31, 2018 | $102.40M | +62.8% |
| Q3 FY2018 | Sep 30, 2018 | $115.75M | +37.8% |
| Q2 FY2018 | Jun 30, 2018 | $63.49M | -38.1% |
| Q1 FY2018 | Mar 31, 2018 | $79.26M | +41.4% |
| Q4 FY2017 | Dec 31, 2017 | $62.90M | -12.6% |
| Q3 FY2017 | Sep 30, 2017 | $84.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $102.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $56.05M | – |
| Q4 FY2016 | Dec 31, 2016 | $72.00M | – |
See a number that looks wrong?